Disturbed bile secretion and cytochrome P-450 function during the acute state of experimental colitis in rats

Journal of Hepatology

Volumn 32, Issue 5, 2000, Pages 708-717

  Weidenbach, Hans ^a   Leiz, Steffen ^a   Nussler, Andreas K ^b   Dikopoulos, Nektarios ^a   Bachem, Max ^b   Buttenschoen, Klaus ^b   Reinshagen, Max ^a   Beger, Hans G ^b   Adler, Guido ^a   Schmid, Roland M ^a  

^a UNIVERSITY OF ULM   (Germany)

^b R ^*

Author keywords

Liver function; NF B Rel; NOS2; TNB colitis

Indexed keywords

BILE ACID; CYTOCHROME P450;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE SECRETION; COLITIS; CONTROLLED STUDY; ENTERITIS; GLUCOSE TRANSPORT; GLYCOGEN ANALYSIS; LIVER FUNCTION; LIVER METABOLISM; MALE; METABOLIC CAPACITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034019577     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80238-X     Document Type: Article

References (46)

1. Dordal E, Glagov S, Kirsner JB. Hepatic lesions in chronic inflammatory bowel disease. I. Clinical correlations with liver biopsy diagnoses in 103 patients. Gastroenterology. 52:1967;239-253.
2. Wewer V, Gluud C, Schlichting P, Burcharth F, Binder V. Prevalence of hepatobiliary dysfunction in a regional group of patients with chronic inflammatory bowed disease. Scand J Gastroenterol. 26:1991;97-102.
3. Wiesner RH. Liver and billiary abnormalities in ulcerative colitis and Crohn's disease. Blum HE, Bode C, Bode JC, Sartor RB. Gut and the Liver. 1998;81-97 Kluwer Academic Publishers, Hingham MA.
4. Sherlock S. Pathogenesis of sclerosing cholangitis: the role of nonimmune factors. Semin Liver Dis. 11:1991;5-10.
5. Hobson CH, Butt TJ, Ferry DM, Hunter J, Chadwick VS, Broom MF. Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis. Gastroenterology. 94:1988;1006-1013.
6. Brand HS, Maas MA, Bosma A, Van Ketel RJ, Speelman P, Chamuleau RA. Experimental colitis in rats induces low-grade endotoxinemia without hepatobiliary abnormalities. Dig Dis Sci. 39:1994;1210-1215.
7. Reinshagen M, Patel A, Sottili M, French S, Sternini C, Eysselein VE. Action of sensory neurons in an experimental colitis model of injury and repair. Am J Physiol. 270:1996;G79-G86.
8. Weidenbach H, Beckh K, Gunthor M, Lerch MM, Adler G. The role of nitric oxide in hemodynamic and metabolic alterations induced by prostaglandin F2 alpha in the perfused rat liver. Biochim Biophys Acta. 1245:1995;181-186.
9. Weidenbach H, Nussler AK, Shu Z, Adler G, Beckh K. Nitric oxide formation lowers norepinephrine-induced intrahepatic resistance without major effects on the metabolism in the perfused rat liver. Hepatology. 26:1997;147-154.
10. Reichen J, Paumgartner G. Kinetics of taurocholate uptake by the perfused rat liver. Gastroenterology. 68:1975;132-136.
11. Bergmeyer HU, Grassl M, Walter HE. Reagents for enzymatic analysis. Bergmeyer HU. Methods of Enzymatic Analysis. 1985;154-155 Verlag Chemie, Weinheim - Deerfield Beach, Florida - Basel.
12. Staver E, Gilhuus-Moe CC, Osuga T. 3α-Hydroxy bile acids. Bergmeyer HU. Methods of Enzymatic Analysis. 1985;281-297 Verlag Chemie, Weinheim - Deerfield Beach, Florida - Basel.
13. Sekizuka E, Grisham MB, Li MA, Deitch EA, Granger DN. Inflammation-induced intestinal hyperemia in the rat: role of neutrophils. Gastroenterology. 95:1988;1528-1534.
14. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
15. Steinle AU, Weidenbach H, Wagner M, Adler G, Schmid RM. NF-kappa B/Rel activation in cerulein pancreatitis. Gastroenterology. 116:1999;420-430.
16. Nussler AK, Di Silvio M, Liu ZZ, Geller DA, Freeswick P, Dorko K, et al. Further characterization and comparison of inducible nitric oxide synthase in mouse, rat, and human hepatocytes. Hepatology. 21:1995;1552-1560.
17. Wang K, Deutschman CS, Clemens MG, De Maio A. Reciprocal expression of phosphoenolpyrovate carboxykinase and acute phase genes during acute inflammation. Shock. 3:1995;204-209.
18. Ceppi ED, Knowles RG, Carpenter KM, Titheradge MA. Effect of treatment in vivo of rats with bacterial endotoxin on fructose 2,6-bisphosphate metabolism and L-pyruvate kinase activity and flux in isolated liver cells. Biochem J. 284:1992;761-766.
19. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem. 269:1994;4705-4708.
20. Taylor BS, de Vera ME, Ganster RW, Wang Q, Shapiro RA, Morris SM Jr, et al. Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J Biol Chem. 273:1998;15148-15156.
21. de Vera ME, Taylor BS, Wang Q, Shapiro RA, Billiar TR, Geller DA. Dexamethasone suppresses iNOS gene expression by upregulating I-kappa B alpha and inhibiting NF-kappa B. Am J Physiol. 273:1997;G1290-G1296.
22. Liu MS, Ghosh S. Changes in beta-adrenergic receptors in dog livers during endotoxic shock. Am J Physiol. 244:1983;R718-R723.
23. Hwang TL, Lau YT, Huang SF, Chen MF, Liu MS. Changes of alpha 1-adrenergic receptors in human liver during intraabdominal sepsis. Hepatology. 20:1994;638-642.
24. Martinolle JP, Garcia Villar R, Fioramonti J, Bueno L. Altered contractility of circular and longitudinal muscle in TNBS-inflamed guinea pig ileum. Am J Physiol. 272:1997;G1258-G1267.
25. Pol O, Valle L, Ferrer I, Puig MM. The inhibitory effects of alpha(2)-adrenoceptor agonists on gastrointestinal transit during croton oil-induced intestinal inflammation. Br J Pharmacol. 119:1996;1649-1655.
26. Lora L, Mazzon E, Martines D, Fries W, Muraca M, Martin A, et al. Hepatocyte tight-junctional permeability is increased in rat experimental colitis. Gastroenterology. 113:1997;1347-1354.
27. Green RM, Beier D, Gollan JL. Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology. 111:1996;193-198.
28. Bolder U, Ton Nu HT, Schteingart CD, Frick E, Hofmann AF. Hepatocyte transport of bile acids and organic anions in endotoxemic rats: impaired uptake and secretion. Gastroenterology. 112:1997;214-225.
29. Trauner M, Arrese M, Lee H, Boyer JL, Karpen SJ. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J Clin Invest. 101:1998;2092-2100.
30. Chen JQ, Strom A, Gustafsson JA, Morgan ET. Suppression of the constitutive expression of cytochrome P-450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in the suppressive response to interleukins 1 and 6. Mol Pharmacol. 47:1995;940-947.
31. Sewer MB, Barclay TB, Morgan ET. Down-regulation of cytochrome P450 mRNAs and proteins in mice lacking a functional NOS2 gene. Mol Pharmacol. 54:1998;273-279.
32. Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 14:1996;649-683.
33. Schreiber S, Nikolaus S, Hampe J. Activation of nuclear factor kappa B in inflammatory bowel disease. Gut. 42:1998;477-484.
34. Rogler G, Brand K, Vogl D, Page S, Hofmeister R, Andus T, et al. Nuclear factor kappa B is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology. 115:1998;357-369.
35. Wahl C, Liptay S, Adler G, Schmid RM. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest. 101:1998;1163-1174.
36. Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, Strober W. Local administration of anti sense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med. 2:1996;998-1004.
37. Jobin C, Haskill S, Mayer L, Panja A, Sartor RB. Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells. J Immunol. 158:1997;226-234.
38. Laskin DL, Rodriguez del Valle M, Heck DE, Hwang SM, Ohnishi ST, Durham SK, et al. Hepatic nitric oxide production following acute endotoxemia in rats is mediated by increased inducible nitric oxide synthase gene expression. Hepatology. 22:1995;223-234.
39. Luss H, DiSilvio M, Litton AL, Molina Y, Nussler AK, Billiar TR. Inhibition of nitric oxide synthesis enhances the expression of inducible nitric oxide synthase mRNA and protein in a model of chronic liver inflammation. Biochem Biophys Res Commun. 204:1994;635-640.
40. Sartor RB. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am. 24:1995;475-507.
41. Blackwell TS, Blackwell TR, Christman JW. Impaired activation of nuclear factor-kappaB in endotoxin-tolerant rats is associated with down-regulation of chemokine gene expression and inhibition of neutrophilic lung inflammation. J Immunol. 158:1997;5934-5940.
42. Szabo C, Thiemermann C, Wu CC, Perretti M, Vane JR. Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci USA. 91:1994;271-275.
43. Bundschuh DS, Barsig J, Hartung T, Randow F, Docke WD, Volk HD, et al. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice. J Immunol. 158:1997;2862-2871.
44. Beckh K, Kneip S, Arnold R. Direct regulation of bile secretion by prostaglandins in perfused rat liver. Hepatology. 19:1994;1208-1213.
45. Weidenbach H, Scheibner J, Stange EF, Adler G, Beckh K. Reduction of bile secretion by prostaglandins in the rat in vivo. Life Sci. 58:1996;1531-1538.
46. Ruhl A, Berezin I, Collins SM. Involvement of eicosanoids and macrophage-like cells in cytokine-mediated changes in rat myenteric nerves. Gastroenterology. 109:1995;1852-1862.